Heng Xu is an accomplished biostatistician with extensive experience in the pharmaceutical industry. Currently serving as Principal Biostatistician at Nektar Therapeutics since June 2018, Heng previously held the position of Senior Biostatistician in the same company. Prior experience includes a role as Senior Statistician at Takeda from September 2017 to May 2018, and an ORISE Fellowship at the FDA from January 2017 to July 2017. Heng Xu earned a PhD in Statistics from Purdue University (2012-2017), a Master's degree in Statistics from Indiana University–Purdue University Indianapolis (2011-2012), and a Bachelor's degree in Applied Mathematics from Zhejiang University (2006-2010).
This person is not in the org chart
This person is not in any teams